2012
DOI: 10.1016/j.neulet.2012.02.006
|View full text |Cite
|
Sign up to set email alerts
|

3,3′,4′,5,5′-Pentahydroxyflavone is a potent inhibitor of amyloid β fibril formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(30 citation statements)
references
References 20 publications
1
29
0
Order By: Relevance
“…Fisetin, a quercetin analog without the 5-OH group on the A-ring, also inhibited the aggregation of A␤42 (58). Ushikubo et al (59) reported that the 7-OH group on the A-ring is not involved in the anti-aggregative ability of flavonols. These are consistent with our previous study on the structure-activity relationship of (ϩ)-taxifolin (23).…”
Section: Discussionmentioning
confidence: 99%
“…Fisetin, a quercetin analog without the 5-OH group on the A-ring, also inhibited the aggregation of A␤42 (58). Ushikubo et al (59) reported that the 7-OH group on the A-ring is not involved in the anti-aggregative ability of flavonols. These are consistent with our previous study on the structure-activity relationship of (ϩ)-taxifolin (23).…”
Section: Discussionmentioning
confidence: 99%
“…Because of its close structural homology with fisetin (3,3Ј,4Ј,7-tetrahydroxyflavone) (27), a neurotrophic molecule that has been shown previously to inhibit amyloid aggregation (28), we hypothesized that cromolyn sodium may potentially prevent A␤ oligomerization and promote A␤ clearance in vitro and in vivo. In addition, the use of cromolyn sodium in addiction models (after subcutaneous infusion (29,30)) and the physical properties of this molecule (molecular weight: 508.38; polar surface area: 125; and LogP: 1.39) argue for cromolyn sodium as a bloodbrain barrier-permeable drug, therefore allowing systemic infusion.…”
Section: Therapies To Prevent Alzheimer Disease (Ad)mentioning
confidence: 99%
“…Because of its structural similarities with fisetin (3,3Ј,4Ј,7-tetrahydroxyflavone, Fig. 1A), a flavonoid compound that has been previously shown to inhibit A␤ polymerization (27,28), we hypothesized that cromolyn sodium may also impact A␤ aggregation processes and modulate A␤ metabolism in vitro and in vivo. To test this hypothesis, we first evaluated the effect of cromolyn sodium on A␤ 40 and A␤ 42 fibrillization using a Thioflavin-T assay.…”
Section: Cromolyn Sodium Inhibits A␤ Polymerization In Vitro Butmentioning
confidence: 99%
“…The array of natural phenols being tested as potential inhibitors of amyloid aggregation becomes wider and wider every day and now includes also tannic acid [207,313] and the product of tannin hydrolysis ellagic acid [314]; several flavones, like apigenin [315,316], baicalein [315,317,318], kaempferol [260,261,263,264,271,319], morin [265,320,321], fisetin [259,260,321], rutin (the glycoside of quercetin with the disaccharide rutinose) [322,323] and luteolin [260,324]; rottlerin, already known as a PKC-δ inhibitor [325,326]; the anthocyanidin malvidin, the main responsible for the red color of wine [327]; the stilbenes piceatannol [328] and the resveratrol-derived dimer ɛ-viniferin glucoside [329]; and, finally, ferulic acid (related to trans-cinnamic acid) [189,263,264,330332]. …”
Section: The Anti-amyloid Properties Of Natural Phenols and Polyphmentioning
confidence: 99%